Moderna News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

07.11.24	Moderna Turns To Profit In Q3; Backs FY24 Net Product Sales View; Stock Up (RTTNews)
12.09.24	Moderna Issues Outlook For FY25 And Beyond, Cuts R&D Budget; Stock Down In Pre-market (RTTNews)
10.09.24	Carisma, Moderna To Expand Collaboration; Moderna Nominates Two Autoimmune Disease Targets (RTTNews)
25.08.24	Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug (RTTNews)
23.08.24	FDA Approves Updated Pfizer, Moderna Covid Vaccines Against Current Variants (RTTNews)
01.08.24	Moderna Posts Wider-than-expected Q2 Loss, Revenues Down; Revises Outlook; Stock Dips In Pre-market (RTTNews)
09.07.24	Moderna, Mitsubishi Tanabe To Co-Promote MRNA Respiratory Vaccines In Japan, Incl. COVID-19 Vaccine (RTTNews)
02.07.24	Moderna Awarded $176 Mln To Develop MRNA Influenza Vaccines (RTTNews)
28.06.24	Moderna Says CHMP Recommends Marketing Authorization For MRESVIA RSV Vaccine In EU (RTTNews)
13.06.24	Moderna: MRNA-1283 Meets Primary Vaccine Efficacy Endpoint In Phase 3 (RTTNews)
10.06.24	Moderna Reports Positive Phase 3 Data For Flu And COVID Combination Vaccine (RTTNews)
06.06.24	Moderna: FDA Selects MRNA-3705 For START Pilot Program (RTTNews)
03.06.24	Merck Says MRNA-4157-Keytruda Combination Data Shows Improvement In High-Risk Melanoma Patients (RTTNews)
30.05.24	U.S. Govt To Provide Funding For Late-stage Trial Of Moderna's Bird Flu Vaccine (RTTNews)
10.05.24	Moderna: FDA Delays BLA Review Of RSV Vaccine MRNA-1345 (RTTNews)
02.05.24	Moderna, Inc Q1 Earnings Summary (RTTNews)
30.04.24	Biotech Stocks Facing FDA Decision In May 2024 (RTTNews)
04.04.24	Arbutus Biopharma Reports Claim Construction Ruling In Patent Infringement Lawsuit Against Moderna (RTTNews)
03.04.24	Clinical Data Of Moderna's Investigational MRNA Therapy Gets Published In Nature (RTTNews)
27.03.24	Blackstone Invests $750 Mln In Moderna's Influenza Program (RTTNews)
26.03.24	Moderna's MRNA-1283 COVID-19 Vaccine Design Meets Primary Endpoints In Phase 3 Clinical Trial (RTTNews)
22.02.24	Moderna Stock Up 6% As Q4 Results Top Estimates (RTTNews)
22.02.24	Moderna Adds 6% On Better-than-expected Quarterly Results (RTTNews)
22.02.24	Moderna Q4 Profit Down On Lower Covid-19 Product Sales, But Beats Estimates (RTTNews)
08.01.24	Moderna Sees COVID-19 Franchise To Be Profitable In Anticipated Sales Scenarios For 2024 And Beyond (RTTNews)
14.12.23	Moderna, Merck Announce Follow-up Data From Phase 2b KEYNOTE-942/mRNA-4157-P201 Study (RTTNews)
12.12.23	Moderna Announces Changes To Operating Model To Prepare For Product Launches (RTTNews)
21.11.23	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
02.11.23	Moderna Slips To Hefty Loss In Q3; Expects To Return To Sales Growth In FY25, To Break Even In FY26 (RTTNews)
01.11.23	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
24.10.23	Caris Life Sciences, Moderna To Advance MRNA-Based Oncology Therapeutics (RTTNews)
24.10.23	Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics (PR Newswire)
16.10.23	Moderna Reaffirms FY23 COVID-19 Vaccine Revenue Outlook (RTTNews)
04.10.23	Moderna Announces Positive Interim Data For Its Combination Vaccine Against Influenza And COVID-19 (RTTNews)
15.09.23	European Commission Authorises XBB.1.5-adapted Moderna COVID-19 Vaccine (RTTNews)
13.09.23	CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine (RTTNews)
11.09.23	Moderna, Immatics Ink Strategic Multi-Platform Collaboration To Develop Oncology Therapeutics (RTTNews)
11.09.23	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer (PR Newswire)
06.09.23	Moderna Says Clinical Trial Data Shows Updated COVID Vaccine Very Effective Against BA.2.86 Variant (RTTNews)
26.08.23	Alnylam Pharma To Appeal U.S. Court Ruling On Two Patents Asserted Against Moderna (RTTNews)
14.08.23	UMass Chan Medical School announces enrollment in study to examine impact of cytomegalovirus (CMV) transmission in early education settings (PR Newswire)
03.08.23	Moderna Posts Narrower-than-expected Q2 Loss; Backs FY23 Vaccine Sales View; Stock Up In Premarket (RTTNews)
04.05.23	Moderna Q1 Profit, Revenues Down, Yet Beats Market; Backs FY23 COVID-19 Vaccine Sales View (RTTNews)
19.04.23	FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines (RTTNews)
11.04.23	Moderna Issues Clinical Updates; Expects Six Major Vaccine Product Launches In Next Few Years (RTTNews)
23.03.23	Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines (RTTNews)
23.02.23	Moderna Q4 Profit Down, Misses Estimates On Weak COVID-19 Vaccine Sales (RTTNews)
17.02.23	Moderna Reports Mixed Results Of Flu Vaccine MRNA-1010 In Phase 3 Trial; Stock Down (RTTNews)
17.02.23	Pre-market Movers: SNTG, CSWC, AMAM, IXHL, MYNA… (RTTNews)
03.02.23	Personalis, Moderna Continue Partnership On Personalized Cancer Vaccine Program (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

17:58		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
17:58		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
17:58		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
17:58		SLI aktuell: Anleger lassen SLI letztendlich steigen
17:58		SMI aktuell: SMI präsentiert sich letztendlich fester
17:56		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
16:17		Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus
16:06		Bayer-Aktie in Rot: FDA erweitert Zulassung für Bayer-Krebsmedikament Nubeqa

17:58

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone

17:58

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

17:58

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

17:58

SLI aktuell: Anleger lassen SLI letztendlich steigen

17:58

SMI aktuell: SMI präsentiert sich letztendlich fester

17:56

Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an